This web site (the "Company Web Site") contains information about Regenics AS (the “Company”) its business, its strategy and forward looking projections. The web site also contains information on Regenics business partners.  Regenics AS is a biotech company which conduct research, sell products and develops new products.

Any information  on the web site  does not constitute or form part of an offer to sell, purchase, exchange or transfer any shares, securities or a solicitation of any such offer. The web site information is for full public disclosure, its content may be distributed and  copied. The web site may contain proprietary or confidential information, unpublished results under ongoing patent processes and as such is not meant for reuse, neither for commercial nor for other uses. If such uses are contemplated please contact  Regenics AS for further instruction. The Company is under Confidentiality contracts with collaborators and business partners and such obligtions may limit knowledge or dissipation of any material on this web site.

The data on this web site is protected by several US, European and RoW patents. In the US, a.o. US patent US 9,066,883 B2 and various trademarks, protect the information web site. Regenics AS do not grant any ownership, neither solely or jointly to any of its patents, by  access of this web site, either by information sharing, nor from downloading or any other transmission of information. Receiving such information do not imply any ownership, aquisition of IP or permission to include data in publications, commercial material without written permission from Regenics AS.

This web site contains certain forward-looking statements relating to to R&D (Research and development), state of product development  and data that is covered by Regenics patents, in US, EU and RoW.  It may contain data that is unpublished, under review by patent authorities or subject to peer review by scientific journals or by Regulatory or Competent Authorities.  All data, figures, statements, video, images are to our best knowledge produced by Regenics or by permission if not produced by the Company. If material otherwise accidentally have whole or partial ownership by others and such ownership to material is claimed, Regenics wil remove or amend such material upon notice. The web site contain, business, financial performance, research and development information and results of the Company and/or the industry in which it operates. Forward-looking statements concern future circumstances and results and other statements that are not historical facts, sometimes identified by the words “believes”, "expects”, “predicts”, “intends”, “projects”, “plans”, “estimates”, “aims”, “foresees”, “anticipates”, “targets”, “effects”, “inhibition, “stimulation” and similar expressions. Such statements and the magnitude of the claims contemplated , may change. The forward-looking statements contained in this web site, including assumptions, opinions and views of the Company or if they are cited from third party sources are solely opinions and forecasts which are subject to risks, uncertainties and other factors that may cause actual events to differ materially from any anticipated development. None of the Company or any of its subsidiary undertakings or any such person’s officers or employees provides any assurance that the assumptions underlying such forward-looking statements are free from errors nor do any of them accept any responsibility for the future accuracy of the opinions expressed in this Document or the actual occurrence of the forecasted developments. The Company assumes no obligation, except as required by law, to update any forward-looking statements or to conform these forward-looking statements to our actual results.

No representation or warranty (express or implied) is made as to, and no reliance should be placed on, any information, including projections, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and, accordingly, none of the Company or any of its parent or subsidiary undertakings or any such person’s officers or employees accepts any liability whatsoever arising directly or indirectly from the use of this web site.

This Document speaks as of October 2016. Neither the delivery of this Document nor any further discussions of the Company with any of the recipients shall, under any circumstances, create any implication that there has been no change in the affairs of the Company since such date.

 

Regenics AS,

Oslo, Norway

October 2016 

For inquiries on content, distribution, ownership and permissions, please contact Regenics AS

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.